单操作孔电视胸腔镜下非小细胞肺癌根治术的临床疗效分析

目的:总结单操作孔电视胸腔镜治疗非小细胞肺癌的临床效果。方法:选择单一治疗组2013年1月至2016年12月非小细胞肺癌手术患者536例,手术方式均为电视胸腔镜肺癌根治术。其中,167例行三孔术式(三孔组),369例行单操作孔术式(二孔组),比较两组临床疗效。结果:两组间手术时间、术中出血量、清扫淋巴结数目、中转开胸率、术后第1天引流量、术后拔管时间、术后住院时间、术后并发症差异均无统计学意义;二孔组术后第1天、第5天、第30天视觉模拟评分(visual analogue score,VAS)明显低于三孔组(P0.05)。结论:单操作孔电视胸腔镜肺癌根治术的安全性及有效性与三孔电视胸腔镜肺癌根治术无明显差别,但术后疼痛较轻,值得临床推广。

Analysis of Biportal Video-assisted Thoracoscopic Lobectomy in 369 Cases

Objective:Conclude the clinical effect of biportal Video-assisted Thoracoscopic Lobectomy in the treatment of non-small cell lung cancer. Methods: A total of 536 patients with non-small cell lung cancer receiving surgical resection from Jun. 2013 to Dec. 2016 were analyzed retrospectively. The surgery was performed as Video-assisted Thoracoscopic Surgery, by which, 3-portal VATS for 167 patients (Group A) and biportal VATS for remaining 369 patients (Group B). The effect in two groups was compared. Results:Following parameters in two groups were not significant (P>0.05) including operation time, intraoperative blood lose, lymph node dissection number, the intraoperative conversion rate, drainage on 1st day after surgery, duration of chest drainage, duration of hospital stay and incidence of postoperative complications. While, compared with Group A, Visual Analogue Scores (VAS) on 1st day, 5th day and 30th day in Group B were lower significantly. Conclusion:There is no significant difference between biportal VATS and 3-portal VATS in safety and effectiveness. Biportal VATS is a better recommended skill because of less postoperative discomforts.